A detailed history of Smartleaf Asset Management LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Smartleaf Asset Management LLC holds 199 shares of CYTK stock, worth $10,391. This represents 0.0% of its overall portfolio holdings.

Number of Shares
199
Previous 236 15.68%
Holding current value
$10,391
Previous $12.7 Million 17.94%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$51.22 - $60.16 $1,895 - $2,225
-37 Reduced 15.68%
199 $10.4 Million
Q2 2024

Aug 13, 2024

BUY
$47.86 - $75.05 $11,294 - $17,711
236 New
236 $12.7 Million

Others Institutions Holding CYTK

About CYTOKINETICS INC


  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $4.92B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Smartleaf Asset Management LLC Portfolio

Follow Smartleaf Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Smartleaf Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Smartleaf Asset Management LLC with notifications on news.